Logo

NIH Awards $13.7M for Tuberculosis Structural Biology Project

Apr 28, 2006

NEW YORK, April 28 (GenomeWeb News) - The National Institute of Health has awarded $13.7 to a team headed by scientists at the Texas Agricultural Experiment Station to determine the three-dimensional structures of a "large number" of Mycobacterium tuberculosis proteins, Texas A&M said this week.  

 

The team will collaborate with researchers from the University of California, Los Angeles; the University of California, Berkeley; and Los Alamos National Laboratory.

 

The five-year project will use protein crystallography to identify potential drug-binding sites in M. tuberculosis proteins.

 

"We are taking a multi-discipline approach that will identify and characterize new drug targets that are essential for persistent M. tuberculosis," the researchers said the grant abstract in the NIH database. "Targets will be exposed to a battery of analyses including microarray experiments, bioinformatics, and genetic techniques to prioritize potential drug targets from [M. tuberculosis] for structural analysis."

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.